Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorCarmona-Bayonas, Alberto
dc.contributor.authorCustodio, Ana
dc.contributor.authorGarcía Carbonero, Rocío
dc.contributor.authorCapdevila Castillon, Jaume
dc.contributor.authorAlonso-Gordoa, Teresa
dc.contributor.authorGrande, Enrique
dc.date.accessioned2023-09-06T11:03:43Z
dc.date.available2023-09-06T11:03:43Z
dc.date.issued2023-09
dc.identifier.citationCapdevila Castillón J, Alonso Gordoa T, Carmona Bayonas A, Custodio Carretero A, García-Carbonero R, Grande Pulido E, et al. SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022). Clin Transl Oncol. 2023 Sep;25:2692–706.
dc.identifier.issn1699-3055
dc.identifier.urihttps://hdl.handle.net/11351/10244
dc.descriptionDiagnosis; Neuroendocrine; Therapy
dc.description.abstractNeuroendocrine neoplasms (NENs) are a heterogeneous family of tumors of challenging diagnosis and clinical management. Their incidence and prevalence continue to rise mainly due to an improvement on diagnostic techniques and awareness. Earlier detection, along with steadfast improvements in therapy, has led to better prognosis over time for advanced gastrointestinal and pancreatic neuroendocrine tumors. The aim of this guideline is to update evidence-based recommendations for the diagnosis and treatment of gastroenteropancreatic and lung NENs. Diagnostic procedures, histological classification, and therapeutic options, including surgery, liver-directed therapy, peptide receptor radionuclide therapy, and systemic hormonal, cytotoxic or targeted therapy, are reviewed and discussed, and treatment algorithms to guide therapeutic decisions are provided.
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofseriesClinical and Translational Oncology;25
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectTumors neuroendocrins - Tractament
dc.subjectBronquis - Càncer - Tractament
dc.subject.meshNeuroendocrine Tumors
dc.subject.meshBronchial Neoplasms
dc.subject.meshDisease Management
dc.titleSEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1007/s12094-023-03205-6
dc.subject.decstumores neuroendocrinos
dc.subject.decsneoplasias de los bronquios
dc.subject.decstratamiento de las enfermedades
dc.relation.publishversionhttps://doi.org/10.1007/s12094-023-03205-6
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Capdevila Castillón J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Alonso Gordoa T] Servicio de Oncología Médica, Hospital Universitario Ramón y Cajal, Madrid, Spain. [Carmona Bayonas A] Servicio de Oncología Médica, Hospital Universitario Morales Meseguer, Murcia, Spain. [Custodio Carretero A] Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain. [García-Carbonero R] Servicio de Oncología Médica, Hospital Universitario 12 de Octubre, Madrid, Spain. [Grande Pulido E] Servicio de Oncología Médica, MD Anderson Cancer Center, Madrid, Spain
dc.identifier.pmid37204633
dc.identifier.wos000990922300001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record